Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$JUPW trading well this morning, UP almost 2%...
$JUPW trading just over 70% of its 10-day average volume in Power Hour... Testing support levels on the chart.
Very detailed update... Significant progress has been made since the last Letter to Shareholders dated September 15!
*We have launched or restarted two clinical trials for tinnitus and eczema, both conditions with large patient populations.
*We have entered the potentially lucrative market of Female Sexual Wellness and obtained or added to our intellectual property portfolio with the addition of our hair loss therapy.
*We finally had our topical treatment for psoriasis and vitiligo approved by the "FDA of India" and just announced the market launch in India.
*And lastly, we announced record revenues for the Nine Months ending September 30 vs. the corresponding period in 2021.
Excellent comprehensive update on JUPW today detailing the company's positioning, progress and plans to continue its growth:
Jupiter Wellness Issues Letter to Shareholders and Corporate Update
JUPITER, FL / ACCESSWIRE / December 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair, skin, and sexual wellness, issued a Letter to Shareholders today to provide a corporate update since its last report in September.
Dear Shareholders,
I would like to take this opportunity to review the significant progress made by your company since the last Letter to Shareholders dated September 15. We have launched or restarted two clinical trials for tinnitus and eczema, both conditions with large patient populations. We have entered the potentially lucrative market of Female Sexual Wellness and obtained or added to our intellectual property portfolio with the addition of our hair loss therapy. We finally had our topical treatment for psoriasis and vitiligo approved by the "FDA of India" and just announced the market launch in India. And lastly, we announced record revenues for the Nine Months ending September 30 vs. the corresponding period in 2021.
We have compiled a quick summary of recent developments and an overview of our products and their current disposition - whether already on the market and generating revenues, currently in clinical trials, or in development:
Jupiter Wellness Corporate Development Highlights
Signed an exclusive licensing agreement with Rejoy, Inc. to develop prescription products for the treatment of nipple neuropathies and associated sexual problems in women that have been treated for breast cancer. The exclusive license includes issued patents and technology, including all formulations. In initial clinical studies, one topical formulation enhanced nipple sensitivity and alleviated associated sexual problems such as increased female sexual lubrication and improved overall orgasmic response. The Company plans to file for a pre-IND meeting with the US FDA within the next 12 months and intends to seek Orphan Drug Designation (ODD). The benefits of an ODD include up to a 50% tax credit for clinical trials that qualify, waiver of Prescription Drug User Fee Amendments (PDFUA) application fees, including the New Drug Application (NDA) and Biologics License Application (BLA), eligibility for Federal research grants and a 7-year market exclusivity.
United States Patent and Trademark Office (USPTO) granted a notice of allowance for patent application No. 16/747,685, titled "Minoxidil Adjuvant Therapies." The patent encompasses the composition and methods for inducing (up-regulating) the expression of sulfotransferases in the hair follicles on the scalp. It has been shown that the induction of the sulfotransferase enzyme in hair follicles increases the sulfonation capacity of minoxidil, thereby increasing the response level to oral and topical minoxidil in the treatment of alopecia.
Announced the initiation of a triple-blinded clinical study evaluating a possible treatment for tinnitus. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus. During the COVID-19 pandemic, Jupiter Wellness scientists identified a novel pathway for the treatment of COVID-19-induced tinnitus and possibly subjective tinnitus. The discovery led to a patent recently filed by Jupiter Wellness for the use of dopamine receptor modulation for the treatment of tinnitus. The Company launched a study to investigate if dopamine receptor modulation can be used effectively to treat COVID-19-induced tinnitus (https://clinicaltrials.gov/ct2/show/NCT05507372). Currently, there is no effective treatment available for patients suffering from tinnitus.
Company's Photocil product (branded as PhotoFirst in India) has been approved by the CDSCO for sale in India. The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, Ministry of Health & Family Welfare, is the National Regulatory Authority (NRA) of India. Photocil is a topical product that filters UV rays from the sun to allow only the therapeutic UV spectrum to penetrate the skin and is used for the treatment of psoriasis and vitiligo. After this market approval, Eris Oaknet Healthcare Pvt Ltd (Eris Oaknet) and Cosmofix Technovation Pvt Ltd (Cosmofix) had market launch meetings for Photocil products for the Indian market in November. The incidence of psoriasis among total skin patients in India ranged between 0.44 and 2.2%, with overall incidence of 1.02% (hyperlink: https://ijdvl.com/psoriasis-in-india-prevalence-and-pattern/). The overall prevalence of vitiligo (hyperlink: https://pubmed.ncbi.nlm.nih.gov/4054593/ ) is about 5 per 1,000 individuals. India has a population of 1.412 billion.
Announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ"). The planned dual listing on Upstream is designed to provide Jupiter Wellness the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in Jupiter Wellness.
Re-opened patient enrollment in a clinical trial to evaluate the superiority of JW-100, a novel cannabidiol topical cream, in a head-to-head study against EUCRISA, an FDA Approved topical treatment for eczema developed by Pfizer. The initial study was put on hold to solve stability issues which were resolved in the original JW-100 formulation.
The Company reported $1.57 million in revenues for the three months that ended September 30, 2022, compared to $688K for the same period in 2021, a 228% increase. In addition to the revenues booked in the Third Quarter, Jupiter Wellness's wholly-owned subsidiary, SRM Entertainment, received $3.6 million in guaranteed purchase orders, with revenues realized once orders are shipped. For the Nine Months that ended Sept. 30, revenues were $5.29 Million vs. $1.33 Million, representing a 398% increase over the First Nine Months of 2021.
On October 25, Jupiter Wellness Acquisition Corp., of which Jupiter Wellness is the sponsor and owns a considerable stake, entered into a definitive business combination agreement with Chijet Motor Company, Inc., which is developing next-generation electric vehicles and expanding its manufacturing capabilities. The deal is expected to be consummated in the next three months.
The Company retired an additional 391,000 shares to treasury from our share buyback program that ended in June.
Product Overview of Jupiter Wellness Products
Minoxidil Booster (TM) - Topical treatment designed to improve Minoxidil efficacy (Approved and on the market)
Photocil (TM) - Topical treatment for psoriasis and vitiligo (Licensed and on the market)
NoStingz (TM) - Topical protection from jellyfish, sea lice, and UVA/UVB rays (Approved and on the market)
JW-100 - Topical treatment of eczema (Currently in development)
JW-300 - Topical treatment of first-degree burns and sun exposure (Currently in development)
JW-400 - Topical treatment of cold sores (Currently in development)
JW-500 - Topical treatment for female sexual wellness (Currently in development)
JW-600 - Treatment for COVID-19-induced tinnitus (Clinical trials underway)
As we head into the end of 2022, we look forward to capitalizing on the progress we have made in building a foundation for continued revenue growth, monetizing our clinical trial programs, building profitability, and enhancing shareholder value.
Please accept my thanks and the gratitude of our entire executive team for your continued support of Jupiter Wellness.
Happy Holidays.
/s/ Brian John
Chief Executive Officer, Jupiter Wellness
About Jupiter Wellness
Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The Company's product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements, and licensing royalties.
Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for Email Alerts at https://jupiterwellness.com/email-alerts/ and by following Jupiter Wellness on Twitter and LinkedIn.
Media Contact
Phone: 561-244-7100
Email: media@jupiterwellness.com
Investor Contact
Phone: 561-244-7100
Email: investors@jupiterwellness.com
Forward-Looking Statements
This communication contains forward-looking statements regarding Jupiter Wellness, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company's current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Jupiter Wellness' control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness, including those described from time to time under the caption "Risk Factors" and elsewhere in Jupiter Wellness' Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness' Annual Report on Form 10-K for the year ended December 31, 2021, and future filings and reports by Jupiter Wellness. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies' forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations, or other circumstances that exist after the date on which the forward-looking statements were made.
SOURCE: Jupiter Wellness Inc.
View source version on accesswire.com:
https://www.accesswire.com/730279/Jupiter-Wellness-Issues-Letter-to-Shareholders-and-Corporate-Update
$JUPW News! Jupiter Wellness Issues Letter to Shareholders and Corporate Update https://finance.yahoo.com/news/jupiter-wellness-issues-letter-shareholders-133000737.html
$JUPW has shown significant growth year over year.
$JUPW News December 05, 2022
Jupiter Wellness Appoints Ardis Enterprises as the Exclusive Florida Market Distributor for its NoStingz and CaniSun Lines of Sunscreen
https://finance.yahoo.com/news/jupiter-wellness-appoints-ardis-enterprises-133000478.html
$JUPW IN THE SECOND QUARTER OF 2022 REVENUES SURPASSED $3 MILLION WHICH IS A FIVE-FOLD INCREASE OVER THE SAME PERIOD IN 2021 THE COMPANY GENERATED $1,569,925 IN REVENUES FOR THE 3RD QUARTER COMPARED TO $687,928 FOR THE SAME PERIOD IN 2021.
$JUPW News November 18, 2022
Jupiter Wellness Regains Compliance with Nasdaq Minimum Bid Price Requirement
Jupiter Wellness, Inc. (Nasdaq:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness, announced today that it had received a written letter from Nasdaq, which has determined that the Company has met the minimum bid requirement from November 4th to November 17, 2022. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.
https://finance.yahoo.com/news/jupiter-wellness-regains-compliance-nasdaq-180000655.html
Just bought back in at .86. This is a great stock for 30 percent scalp trades. Always hold some for longer term. Bet we are over $1.20 soon this go around.
Yes. Chart is shaping up!
Anyone see this on Reddit? Not much detail, but it got me looking at JUPW. I like beatup stocks. THis fits the bill. lol
https://www.reddit.com/r/pennystocks/comments/wutfet/penny_stocks_near_52week_lows_and_headed_up_bfri/
$JUPW NEWS! Jupiter Wellness Developing Novel Women’s Sexual Health Product https://finance.yahoo.com/news/jupiter-wellness-developing-novel-women-123000608.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$JUPW - Jupiter has received an upfront payment and is entitled to royalties of between 10-12% on revenues for the three products with guaranteed annual minimum royalty payments for the duration of the agreement in 31 countries in Asia and the Middle East including India, the Philippines, Malaysia, Kuwait, Morocco, and Saudi Arabia.
$JUPW holding steady on low volume compared to its 10-day average volume.
$JUPW trading only a quarter of its average volume but its BID is higher than yesterday's close and overall it's green.
$JUPW Latest News and Headlines https://www.barchart.com/stocks/quotes/JUPW/news
Yes, and couple that with the follow up News from yesterday... And there's huge potential!
Jupiter receives upfront payment plus double-digit royalties on revenues in 31 countries for clinically proven minoxidil (Rogaine®) products Minoxidil Booster and After Minoxidil Spray, and Photoci, a patented topical cream clinically proven to provide relief from psoriasis, vitiligo, and eczema
The latest news from JUPW on its new licensing agreement for the Minoxidil product for the Japanese market looks like a high value revenue driver. This is a really nice expansion of the wellness areas where the company is focused and holds a lot of potential for future growth.
Jupiter Wellness Licenses Minoxidil Booster to Taisho
June 23, 2022 (Accesswire)
Taisho to introduce a minoxidil booster developed by Applied Biology to boost minoxidil efficacy for Androgenetic Alopecia patients that do not respond to minoxidil
The minoxidil sulfotransferase enzyme booster (SULT1A1) was acquired by Jupiter Wellness in an acquisition of assets that included issued patents, patent applications, products, clinical trial results, and licensing agreements from Applied Biology
JUPITER, FL / ACCESSWIRE / June 23, 2022 / Jupiter Wellness (NASDAQ:JUPW) and Taisho Pharmaceutical Co. Ltd (TYO:4581) today announced that Taisho Pharmaceutical has entered into a license agreement for Jupiter Wellness's minoxidil booster for the Japanese market.
Minoxidil is the only US FDA-approved topical drug for the treatment of common hair loss (androgenetic alopecia). Although there are racial and geographical differences, minoxidil is clinically effective in 30-40% of patients. Applied Biology scientists discovered that minoxidil efficacy is dependent on the minoxidil sulfotransferase enzyme (also called SULT1A1) found in hair. After the breakthrough discovery, Applied Biology scientists developed a novel adjuvant minoxidil treatment, the Minoxidil Sulfotransferase Enzyme (SULT1A1) Booster, that demonstrated in clinical trials to increase minoxidil efficacy (Dhurat R, Daruwalla S, Pai S, Kovacevic M, McCoy J, Shapiro J, Sinclair R, Vano-Galvan S, Goren A). The Minoxidil Sulfotransferase Enzyme (SULT1A1) Booster significantly improves response to topical minoxidil for hair regrowth (J Cosmet Dermatol. 2022 Jan;21(1):343-346. doi: 10.1111/jocd.14299. Epub 2021 Jun 25. PMID: 34133836).
In a bid to help hair loss patients in Japan, Taisho Pharmaceutical, the largest minoxidil manufacturer, and a leader in hair therapies in Japan is now planning to support hair loss patients with this breakthrough adjuvant therapy to topical minoxidil.
About Taisho Pharmaceutical
Founded in 1912, Taisho Pharmaceutical Co., Ltd. (https://www.taisho.co.jp/global/), headquartered in Tokyo, Japan is a pharmaceutical company developing both Rx and OTC pharmaceuticals. Taisho has a strong presence in OTC categories, with the No.1 sales in Japan and the 7th largest in the world. Taisho has various well-known products, and they are widely accepted by consumers. RiUP is one of such famous brands, and as the first Minoxidil hair loss product in Japan, it has over 80% of the market share in Japan. Taisho continuously aims for further innovation to improve consumers' health.
About Jupiter Wellness
Jupiter Wellness translates innovative health science into revolutionary products aimed at skin, hair, sexual wellness, and general health. Our approach is defined by proven mechanisms of action, validated manufacturing processes, and controlled clinical trials. Our development pipeline includes products to address psoriasis, eczema, burns, herpes, cold sores, and skin cancer. Jupiter Wellness generates revenue from a growing line of over-the-counter skin care products, wellness brands sold through retail channels, and the licensing of our intellectual property and proprietary formulations. For more information, please visit www.JupiterWellness.com.
Investor Contact
Phone: 561-462-2626
Email: investors@jupiterwellness.com
Forward-Looking Statements
This communication contains forward-looking statements regarding Jupiter Wellness, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company's current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Jupiter Wellness' control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness and, including those described from time to time under the caption "Risk Factors" and elsewhere in Jupiter Wellness' Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness' Annual Report on Form 10-K for the year ended December 31, 2021, and future filings and reports by Jupiter Wellness. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies' forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations, or other circumstances that exist after the date on which the forward-looking statements were made.
###
SOURCE: Jupiter Wellness, Inc.
View source version on accesswire.com:
https://www.accesswire.com/705779/Jupiter-Wellness-Licenses-Minoxidil-Booster-to-Taisho
HUGE News from $JUPW! Jupiter Wellness, Inc. today announced it has signed an agreement with India-based companies Cosmofix Technology Pvt Ltd and Sanpellegrino Cosmetics Pvt Ltd for the manufacture, sale, and distribution of three proprietary products related to its recent acquisition of Ascent Clinical Research. Jupiter has received an upfront payment and is entitled to royalties of between 10-12% on revenues for the three products with guaranteed annual minimum royalty payments for the duration of the agreement in 31 countries in Asia and the Middle East including India, the Philippines, Malaysia, Kuwait, Morocco, and Saudi Arabia.
$JUPW News! Jupiter Wellness Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Photoci(TM) Products https://finance.yahoo.com/news/jupiter-wellness-expands-distribution-asia-123000380.html
$JUPW News! Jupiter Wellness Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Photoci(TM) Products https://finance.yahoo.com/news/jupiter-wellness-expands-distribution-asia-123000380.html
I'm expecting follow up News on this development... $JUPW
In a bid to help hair loss patients in Japan, Taisho Pharmaceutical, the largest minoxidil manufacturer, and a leader in hair therapies in Japan is now planning to support hair loss patients with this breakthrough adjuvant therapy to topical minoxidil.
$JUPW Taisho to introduce a minoxidil booster developed by Applied Biology to boost minoxidil efficacy for Androgenetic Alopecia patients that do not respond to minoxidil
#MondayMotivation
https://finance.yahoo.com/news/jupiter-wellness-licenses-minoxidil-booster-123000446.html
Great $JUPW News last Thursday
June 23, 2022
Jupiter Wellness Licenses Minoxidil Booster to Taisho https://finance.yahoo.com/news/jupiter-wellness-licenses-minoxidil-booster-123000446.html
$JUPW Latest News and Headlines https://www.barchart.com/stocks/quotes/JUPW/news
Great News for $JUPW and Taisho Pharmaceutical...
In a bid to help hair loss patients in Japan, Taisho Pharmaceutical, the largest minoxidil manufacturer, and a leader in hair therapies in Japan is now planning to support hair loss patients with this breakthrough adjuvant therapy to topical minoxidil.
Taisho to introduce a minoxidil booster developed by Applied Biology to boost minoxidil efficacy for Androgenetic Alopecia patients that do not respond to minoxidil
The minoxidil sulfotransferase enzyme booster (SULT1A1) was acquired by Jupiter Wellness in an acquisition of assets that included issued patents, patent applications, products, clinical trial results, and licensing agreements from Applied Biology
$JUPW NEWS as Jupiter Wellness Licenses Minoxidil Booster to Taisho https://finance.yahoo.com/news/jupiter-wellness-licenses-minoxidil-booster-123000446.html
$JUPW NEWS! Jupiter Wellness Licenses Minoxidil Booster to Taisho https://finance.yahoo.com/news/jupiter-wellness-licenses-minoxidil-booster-123000446.html
Great additions to the $JUPW team
"These appointments add world-class R&D expertise spanning concept through clinical development, IP development, and commercialization," said Dr. Glynn Wilson, Chairman & Chief Scientific Officer of Jupiter Wellness. "They will greatly enhance our scientific team."
$JUPW NEWS! Dr. Andy Goren and Dr. John McCoy Appointed to Senior Scientific Positions at Jupiter Wellness https://finance.yahoo.com/news/dr-andy-goren-dr-john-123000778.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Great $JUPW News...great shareholder value.
Assets include issued patents, patent applications, products, clinical trial results, licensing agreements
Applied Biology generated approximately $8 million in revenues and $3 million in EBITDA in 2021 (unaudited)
Regulatory expertise with US FDA, EMA, KFDA (Korea), PMDA (Japan), ANVISA (Brazil), CFDA (China)
$JUPW News June 21, 2022 from Yahoo Finance
Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
https://finance.yahoo.com/news/jupiter-wellness-acquires-assets-applied-123000486.html
Jupiter Wellness JUPW Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
https://www.streetinsider.com/dr/news.php?id=20235047&gfv=1
$JUPW News Out! Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
https://www.streetinsider.com/dr/news.php?id=20235047&gfv=1
A fabulous PR... $JUPW now trading 37x its 10-day average volume as lunchtime comes to a close... UP 18% still!
Very welcome news from JUPW today on another significant move to enhance shareholder value by reducing the company's share structure in conjunction with the ongoing share buy-back program. This is a great way to build investor confidence
Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares
JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of 2,433,894 common shares, which reduces the Company's outstanding common shares to 22,151,528, an approximate 10% reduction in shares outstanding.
The Company previously announced a $5.0 million share buyback program. Under the program, shares of the Company's stock may be repurchased periodically in the open market or privately negotiated transactions. To date, the Company has purchased 2,433,894 under the program.
"We continue to believe our stock is undervalued and today's announcement shows continued commitment to our shareholders and the desire to retire shares at current market prices. Given our current cash position, I strongly feel this program is an attractive use of capital as we continue to reposition ourselves for the growth ahead," said Brian John CEO.
About Jupiter Wellness
Jupiter Wellness translates innovative health science into revolutionary products aimed at skin, hair, sexual wellness, and general health. Our approach is defined by proven mechanisms of action, validated manufacturing processes, and controlled clinical trials. Our development pipeline includes products to address psoriasis, eczema, burns, herpes, cold sores, and skin cancer. Jupiter Wellness generates revenue from a growing line of over-the-counter skin care products, wellness brands sold through retail channels, and the licensing of our intellectual property and proprietary formulations. For more information, please visit http://www.JupiterWellness.com.
Media Contact
Phone: 561-244-7100
Email: info@JupiterWellness.com
Investor Contact
Phone: 561-244-7100
Email: investors@jupiterwellness.com
Forward-Looking Statements
This communication contains forward-looking statements regarding Jupiter Wellness, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company's current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Jupiter Wellness' control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness and, including those described from time to time under the caption "Risk Factors" and elsewhere in Jupiter Wellness' Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness' Annual Report on Form 10-K for the year ended December 31, 2021 and future filings and reports by Jupiter Wellness. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies' forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.
SOURCE: Jupiter Wellness Acquisition Corp
View source version on accesswire.com:
https://www.accesswire.com/705519/Jupiter-Wellness-Announces-the-Retirement-of-Approximately-10-of-its-Outstanding-Shares
$JUPW trading nearly 30x its 10-day average volume within the first 30 minutes of the day... UP 33% and Looking awesome!
#BreakingNews: $JUPW Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares https://finance.yahoo.com/news/jupiter-wellness-announces-retirement-approximately-124500648.html
$JUPW sunscreen with protection against sharks and jellyfish stings is perfect for places like Hawaii and Australia.
The new products from JUPW with protection against sharks and jellyfish stings should find a very welcome market niche, especially at the times of year when people are heading out for beach and water sport activities.
Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents
Exclusive Worldwide Rights to Patented Shark Repellent Technologies for the Sun and Skin Market Licensed From Shark Defense Technologies, the Leader in Its Field Featured in Numerous Media Outlets Including Discovery Channel's Shark Week and Animal Planet
View Discovery Channel Videos on the Shark Repellent Technology Here:
$JUPW, looking for increasing revenues.
Over the past two years, Jupiter has built a portfolio of award-winning wellness brands including CaniSun, fitCBD, Jack, Wellness CBD 1937, Black Belt CBD, and Felix Ambrosia, as well prescription therapeutics such as Photosil that have been featured in numerous media outlets including the Today Show, CNN, ABC, CBS, Animal Planet, AdWeek, Bloomberg, The Washington Post, Vogue, BuzzFeed, and Forbes. As the Company continues to expand its clinically tested, science-backed wellness, over-the-counter, and prescription pharmaceutical product pipeline, Jupiter's new sales and marketing team is set to drive revenues from current and new products.
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
892
|
Created
|
08/20/21
|
Type
|
Free
|
Moderators ProfitScout jedijazz |
About Safety Shot, Inc
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
DISCLAIMER:
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions.
There is no express or implied solicitation to buy or sell securities.
The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned.
Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only.
No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |